IFC is the largest multilateral investor in private health in emerging markets.
IFC invests in private health care and life sciences companies across the value chain. Our team of health and investment specialists is dedicated to supporting clients with a range of debt and equity products that are not generally available in emerging markets.
IFC's investment work is complemented by advisory services, such as business environment improvement, value-added training, and studies facilitating development of new products, public-private partnerships, and corporate governance improvement.
A company or entrepreneur seeking to establish a new venture or expand an existing enterprise can approach IFC directly. The investment proposal can be submitted to the IFC field office that is closest to the location of the proposed project.
To date, IFC has invested over $3 billion in 180 private health care and life sciences companies in 53 countries.
In 2013 alone, 27 million patients received health care through our clients.